UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
Commission File Number 0-28666
---------
Cusip Number 024600
---------
(Check One):
|_| Form 10-K and Form 10-KSB |_| Form 11-K |_| Form 20-F |_| Form 10-QSB
|_| Form N-SAR
For period ended December 31, 2003.
------------------
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates: N/A
-----
PART I
REGISTRANT INFORMATION
Full name of registrant American Bio Media Corporation
Address of principal executive office (street and number) 122 Smith Road
City, state and zip code Kinderhook, NY 12106
PART II
RULES 12B-25(B) AND (C)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
|_| (b) The subject annual report on Form 10-KSB will be filed on or
before the 15th calendar day following the prescribed due
date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why the Form 10-KSB could
not be filed within the prescribed time period. (Attach extra sheets if needed.)
The Registrant's internal accounting staff has encountered delays in
finalizing the Registrant's financial statements on a timely basis due to
delays in receiving information from third parties. As a result, the Form 10-KSB
for the period ended December 31, 2003 has not been completed and accordingly
this notification is being filed. The registrant expects to file its Form 10-KSB
on or before April 14, 2004.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Keith E. Palmer, Chief Financial Officer (518) 758-8158
--------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been filed? If the
answer is no, please identity report(s).
Yes No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statements to be included in the subject report or portion
thereof?
Yes No
SIGNATURE
AMERICAN BIO MEDICA CORPORATION
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 30, 2004 By: /s/ Edmund M. Jaskiewicz
--------------------------------
Edmund M. Jaskiewicz, President